Oncology
Article
Immunotherapies shape the treatment landscape for hematologic malignancies
Outcomes Research in Review
HIPEC for Ovarian Cancer: Standard of Care or Experimental Approach?
Video
VIDEO: U.S. melanoma incidence hits all-time high
Annual U.S. incidence rates of invasive and in situ melanoma steadily climbed to a new high of 178,560 cases in 2018.
News
Mortality estimates put pancreatic cancer on the map
Rates in Utah and Vermont should have the rest of the country between them in 2018.
Article
Hospitalizations for fracture in patients with metastatic disease: primary source lesions in the United States
FDA/CDC
Imfinzi approved for stage III unresectable NSCLC
News
The T-cell repertoire in NSCLC: Therapeutic implications
New findings regarding the T-cell repertoire in NSCLC patients could have implications for the use of TIL therapy, checkpoint blockade, and more...
News
Transparency lacking in oncology clinical pathways
Health plans are under fire for the hidden conflicts of interest in their clinical pathway panels.
